VAERS Explorer
Back to explore

Report #2841918

Received May 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
16 yrs
State
MI
Recovered
Unknown
Vaccinated
Apr 30, 2021
Onset
Apr 5, 2024
Days to onset
1071
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (PFIZER-BIONTECH))PFIZER\BIONTECH2——

Symptoms (3)

AnxietyAttention deficit hyperactivity disorderDepression

Symptom narrative

anxiety; depression; attention deficit; This is a spontaneous report received from an Other HCP. A 20-year-old male patient received BNT162b2 (BNT162B2), on 30Apr2021 as dose 2, single (Batch/Lot number: unknown) at the age of 16 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (dose 1), administration date: 08Apr2021, for COVID-19 immunization. The following information was reported: ATTENTION DEFICIT HYPERACTIVITY DISORDER (non-serious) with onset 05Apr2024, outcome "unknown", described as "attention deficit"; ANXIETY (non-serious) with onset 02May2024, outcome "unknown"; DEPRESSION (non-serious) with onset 02May2024, outcome "unknown". The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500088407 Same Pt/SD, Diff Dose/AE;